Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CocoaVia is a premium health and wellness brand owned by Mars Edge, a segment of Mars, Incorporated, dedicated to human health through nutrition. The company specializes in the development and commercialization of cocoa flavanol-based dietary supplements, leveraging over 20 years of scientific research into the cardiovascular and cognitive benefits of cocoa phytonutrients. Their products are formulated using the proprietary Cocoapro process, which preserves the bioactive flavanols often destroyed during traditional cocoa processing. CocoaVia's portfolio includes capsules and powdered drink mixes clinically shown to support healthy blood flow and cognitive function by promoting nitric oxide production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CocoaVia.